University of Edinburgh Featured PhD Programmes
Sheffield Hallam University Featured PhD Programmes
University of Leeds Featured PhD Programmes
Birkbeck, University of London Featured PhD Programmes
FindA University Ltd Featured PhD Programmes
"lymphoma"×
10 miles

lymphoma PhD Projects, Programs & Scholarships

We have 10 lymphoma PhD Projects, Programs & Scholarships

  • "lymphoma" ×
  • clear all
Order by 
Showing 1 to 10 of 10
  Role of BTG1 and BTG2 in acute lymphocytic leukaemia and diffuse large B-cell lymphoma
  Dr G S Winkler
Applications accepted all year round

Funding Type

PhD Type

Acute lymphocytic leukaemia (ALL) and diffuse large B-cell lymphoma (DLBCL) is often associated with small deletions of or point mutations in the highly related BTG1 or BTG2 genes.
  mRNA translation reprogramming and metabolic re-wiring in response to ribosome-targeted therapies
  Prof R. Pearson, Dr J Kang
Applications accepted all year round

Funding Type

PhD Type

Increased synthesis and activity of ribosomes are associated with oncogenesis downstream of the major oncogenes including MYC, RAS and PI3K.
  International PhD Programme in Biomedical Sciences Center for Genomic Regulation (CRG), Barcelona

Funding Type

PhD Type

Apply now to boost your scientific career in a center of excellence, backed by first class core facilities and a broad training portfolio in our multidisciplinary, international community.
  Discovery of Antibiotics from Cyanobacteria (TRUMANJ20DTP)
  Dr A Truman
Application Deadline: 25 November 2019

Funding Type

PhD Type

Bacteria have the capacity to produce natural products with exquisite bioactivities, which makes these compounds excellent candidates as medicines and agrochemicals.
  A multiple modality approach for targeting treatment-resistant ovarian cancer
  Dr E. Sanij, Prof R. Pearson
Applications accepted all year round

Funding Type

PhD Type

High-grade serous ovarian cancer (HGSOC) accounts for 70% of ovarian cancer (OvCa) deaths and its five-year survival rate is 43%.
  Tyrosine kinase inhibitors conjugated tumour targeting dyes for the treatment of glioblastoma.
  Dr J Jose, Dr P Choi
Applications accepted all year round

Funding Type

PhD Type

Glioblastoma (GBM) remains a lethal and difficult to treat cancer with a dismal outcome. Although we have a better understanding of the disease progression, a concurrent increase in therapeutic intervention is lagging.
  Development of a high throughput butyrophilin analysis, to complement a holistic immunological analysis tool for clinical diagnosis/prediction of prognosis
  Dr E Soilleux
Application Deadline: 1 January 2020

Funding Type

PhD Type

Working with Nonacus Ltd with Coeliac UK/ Innovate UK and MRC funding, we have developed a high throughput capture-based sequencing tool for T-cell and…
  Investigating models of survivorship care for patients with haematological malignancie.
  Dr D Allsup
Application Deadline: 31 March 2020

Funding Type

PhD Type

The haematological cancers lymphoma, leukaemia and myeloma represent 8% of all cancers and collectively are the fifth commonest cancer.
  Metabolic reprogramming in cancer: starving tumors of essential nutrients to promote cell death
  Dr S Papa
Applications accepted all year round

Funding Type

PhD Type

All the cells in our bodies are programmed to die. As they get older, our cells accumulate toxic molecules that make them sick. In response, they eventually break down and die, clearing the way for new, healthy cells to grow.
  Autoreactive B cells in Sjögren’s syndrome #202014
  Prof L Dustin, Prof C Buckley
Application Deadline: 10 January 2020

Funding Type

PhD Type

Primary Supervisor. Lynn B Dustin, PhD. Secondary Supervisor. Christopher D Buckley DPhil, FRCP. Sjögren’s syndrome (SS) is the second most common rheumatic disease after rheumatoid arthritis and can also arise as a complication of other autoimmune diseases.
Show 10 15 30 per page
  • 1


FindAPhD. Copyright 2005-2019
All rights reserved.